ロード中...
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy
PURPOSE: Although G-CSF is widely used to prevent or ameliorate leukopenia during cytotoxic chemotherapies, its optimal use is still under debate and depends on many therapy parameters such as dosing and timing of cytotoxic drugs and G-CSF, G-CSF pharmaceuticals used and individual risk factors of p...
保存先:
| 出版年: | J Cancer Res Clin Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5794835/ https://ncbi.nlm.nih.gov/pubmed/29103159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-017-2540-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|